Literature DB >> 20596832

Production of proinflammatory cytokines in the human THP-1 monocyte cell line following induction by Tp0751, a recombinant protein of Treponema pallidum.

ShuangQuan Liu1, ShiPing Wang, YiMou Wu, FeiJun Zhao, TieBing Zeng, YueJun Zhang, QiuGui Zhang, DongMei Gao.   

Abstract

The tissue destruction characteristic of syphilis infection may be caused by inflammation due to Treponema pallidum and the ensuing immune responses to the pathogen. T. pallidum membrane proteins are thought to be potent inducers of inflammation during the early stages of infection. However, the actual membrane proteins that induce inflammatory cytokine production are not known, nor are the molecular mechanisms responsible for triggering and sustaining the inflammatory cascades. In the present study, Tp0751 recombinant protein from T. pallidum was found to induce the production of proinflammatory cytokines, including TNF-alpha, IL-1beta and IL-6, in a THP-1 human monocyte cell line. The signal transduction pathways involved in the production of these cytokines were then further investigated. No inhibition of TNF-a, IL-1beta, or IL-6 production was observed following treatment with the SAPK/JNK specific inhibitor SP600125 or with an ERK inhibitor PD98059. By contrast, anti-TLR2 mAb, anti-CD14 mAb, and the p38 inhibitor SB203580 significantly inhibited the production of all three cytokines. In addition, pyrrolidine dithiocarbamate (PDTC), a specific inhibitor of NF-kappaB, profoundly inhibited the production of these cytokines. Tp0751 treatment strongly activated NF-kappaB, as revealed by Western blotting. However, NF-kappaB translocation was significantly inhibited by treatment with PDTC. These results indicated that TLR2, CD14, MAPKs/p38, and NF-kappaB might be implicated in the inflammatory reaction caused by T. pallidum infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20596832     DOI: 10.1007/s11427-010-0038-z

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  7 in total

1.  Similarities in the Markers of Inflammation Between Men With Syphilis and Women With Increased Risk of HIV Acquisition.

Authors:  Noah Kojima; Claire C Bristow; Holden Maecker; Yael Rosenberg-Hasson; Segundo R Leon; Silver K Vargas; Kelika A Konda; Carlos F Caceres; Jeffrey D Klausner
Journal:  Clin Infect Dis       Date:  2015-09-22       Impact factor: 9.079

Review 2.  Some research advances of immune mechanism during infection in China.

Authors:  Wei Yang
Journal:  Sci China Life Sci       Date:  2012-01-07       Impact factor: 6.038

3.  Fibronectin binding to the Treponema pallidum adhesin protein fragment rTp0483 on functionalized self-assembled monolayers.

Authors:  Matthew T Dickerson; Morgan B Abney; Caroline E Cameron; Marc Knecht; Leonidas G Bachas; Kimberly W Anderson
Journal:  Bioconjug Chem       Date:  2012-01-19       Impact factor: 4.774

4.  Polydatin inhibits mast cell-mediated allergic inflammation by targeting PI3K/Akt, MAPK, NF-κB and Nrf2/HO-1 pathways.

Authors:  Jing Ye; Hongmei Piao; Jingzhi Jiang; Guangyu Jin; Mingyu Zheng; Jinshi Yang; Xiang Jin; Tianyi Sun; Yun Ho Choi; Liangchang Li; Guanghai Yan
Journal:  Sci Rep       Date:  2017-09-19       Impact factor: 4.379

5.  Translational medicine in China I: perspectives from Chinese physicians and scientists.

Authors:  Chengyu Jiang
Journal:  Sci China Life Sci       Date:  2012-01-07       Impact factor: 6.038

6.  Combination of the neutrophil to lymphocyte ratio and serum toluidine red unheated serum test titer as a predictor of neurosyphilis in HIV-negative patients.

Authors:  Caifeng He; Xianjin Shang; Wenbei Liu; Shouyun Hang; Jingtao Chen; Chao Ci
Journal:  Exp Ther Med       Date:  2021-01-07       Impact factor: 2.447

7.  The outer membrane protein Tp92 of Treponema pallidum induces human mononuclear cell death and IL-8 secretion.

Authors:  Xi Luo; Xiaohong Zhang; Lin Gan; Chenglong Zhou; Tie Zhao; Tiebing Zeng; Shuangquan Liu; Yongjian Xiao; Jian Yu; Feijun Zhao
Journal:  J Cell Mol Med       Date:  2018-09-14       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.